News

Emkay Global Financial's research report on Dr Lal Pathlabs

DLPL reported a steady Q4, with EBITDA beating street/our estimates by 6% and adj PAT improving 34% on YoY basis. Strong performance in core markets (Delhi NCR), buoyed by network expansion, offset the persistent muted performance of Suburban (mid-single digit revenue growth). Step up in network expansion and focus on bundled testing for illness should support volume growth in coming years; we expect revenue CAGR at 12% over FY25-28E. Margins are likely to contract by ~100bps in FY26 as investments in network and digital initiatives would be partially offset by improving contribution from Swasthfit and operating leverage. A strong net cash balance sheet, industry leading margins, and improving return ratios provide comfort on valuations.

Outlook

We retain BUY on DLPL with unchanged TP of Rs 3,100 for Mar-26E, based on DCF methodology and implying 2-year forward PER of 44x (vs LTA of 48x).

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Dr Lal Pathlabs - 28042025 - emkay

Discover the latest Business News, Budget 2025 News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Sensex Today Jammu Kashmir News Live Ather Energy IPO JNU Poll Results GIFT Nifty India Economy Apple App Store Dalai Lama TS SSC Results 2025 IPL Points Table 2025

Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups

Home Currencies Commodities Pre-Market IPO Global Market Bonds

Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance TrackerNew Fixed Deposits Fixed Deposit Comparison Fixed Income

Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener

Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator

Stock Markets

News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive Topper Learning

About Us Contact Us Advisory Alert Advertise with Us SupportDisclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors

You are already a Moneycontrol Pro user.